Intellia Therapeutics, Inc. (NTLA)
12.37
+0.11
(+0.90%)
USD |
NASDAQ |
May 21, 16:00
12.40
+0.03
(+0.24%)
After-Hours: 19:59
Intellia Therapeutics Research and Development Expense (TTM) : 351.67M for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Recursion Pharmaceuticals, Inc. | 382.53M |
| KalVista Pharmaceuticals, Inc. | 48.42M |
| Beam Therapeutics, Inc. | 415.33M |
| Novavax, Inc. | 345.26M |
| Regeneron Pharmaceuticals, Inc. | 5.526B |